Browsing by Subject Haemophilus influenzae type b

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  

Showing results 1 to 20 of 36  next >
B126_R15-en.pdf.jpg
Accelerating progress towards achievement of Millennium Goal 4 to reduce child mortality: prevention and treatment of pneumonia
Executive Board, 126 ( 2010 )
B126_R15-fr.pdf.jpg
Accélération des progrès pour la réalisation de l’objectif du millénaire pour le développement n°4 tendant à réduire la mortalité des enfants : traitement et prévention de la pneumonie
Conseil exécutif, 126 ( 2010 )
B126_R15-sp.pdf.jpg
Acelerar los progresos hacia el logro del Objetivo de Desarrollo del Milenio 4 para reducir la mortalidad infantil: prevención y tratamiento de la neumonía
Consejo Ejecutivo, 126 ( 2010 )
bu99-0340.pdf.jpg
Elevated levels of maternal anti-tetanus toxin antibodies do not suppress the immune response to a Haemophilus influenzae type b polyribosylphosphate-tetanus toxoid conjugate vaccine / C. Panpitpat ... [et al.]
Panpitpat, Chanatip; Thisyakorn, Usa; Chotpitayasunondh, Tawee; Fürer, Emil; Que, John U; Hasler, Thomas; Cryz, Stanley J ( 2000 )
80(9)690-695.pdf.jpg
Epidemiology of meningitis due to Haemophilus influenzae type b in children in Bulgaria : a prospective, population-based surveillance study / Mira Kojouharova ... [et al.]
Bulgarian Hib Study Team; Kojouharova, Mira; Gatcheva, Nina; Setchanova, Lena; Robertson, Susan E; Wenger, Jay D ( 2002 )
WHO_V-B_01.27_eng.pdf.jpg
Estimating the local burden of Haemophilus influenzae type b (Hib) disease preventable by vaccination : a rapid assessment tool
World Health Organization. Dept. of Vaccines and Biologicals ( 2001 )
WHO_VRD_GEN_95.05.pdf.jpg
Generic protocol for population-based surveillance of haemophilus influenzae type B / prepared by Orin S. Levine ... [et al.]
Levine, Orin S; Schuchat, Anne; Schwartz, Benjamin; Wenger, Jay D; Elliott, John; WHO Global Programme for Vaccines and Immunization ( 1996 )
WHO_V-B_02.18_eng.pdf.jpg
Haemophilus influenzae type b (Hib) meningitis in the pre-vaccine era : a global review of incidence, age distributions, and case-fatality rates
World Health Organization. Dept. of Vaccines and Biologicals ( 2002 )
lau.pdf.jpg
Haemophilus influenzae type B diseases in Asia : editorial / Y.L. Lau
Lau, Y. L ( 1999 )
EMHJ_2001_7_4-5_597_603.pdf.jpg
Haemophilus influenzae type b diseases in children: a pre-vaccination study
Bakir, M.; El Khadir, A.; Devadas, K.; Farrukh, A.S.; Uduman, S.A. ( 2001 )
Abstract

Haemophilus influenzae type b [Hib] can now be prevented by vaccination. We present the clinical and laboratory characteristics of acute invasive H. influenzae diseases in children admitted over a 4-year period to a tertiary paediatric ward of the Al-Ain medical district hospital, before vaccination became available in the United Arab Emirates. In all, 38 children had bacteriologically proven H. influenzae invasive diseases and all the isolates were serotype b. Meningitis was diagnosed in 60.5% of the children and 66% of the studied children were under 12 months. There were no deaths but substantial morbidity occurred in 12 children

Haemophilus influenzae type b immunization : introducing Haemophilus influenzae type B (Hib) conjugate vaccine into national immunization services
World Health Organization. Dept. of Vaccines and Biologicals ( 2001 )
Inmunización contra Haemophilus influenzae tipo b : introducción de la vacuna conjugada contra Haemophilus influenzae tipo B(Hib) en los servicios nacionales de inmunización
World Health Organization. Dept. of Vaccines and Biologicals ( 2001 )
WHO_BS_2014.2239_eng.pdf.jpg
International collaborative study for the calibration of a replacement international standard for the WHO 1st International Standard for Haemophilus influenzae type b polysaccharide
WHO Expert Committee on Biological Standardization; World Health Organization ( 2014 )
WHO_BS_05.2018_eng.pdf.jpg
International collaborative study to evaluate a candidate international standard for Haemophilus Influenzae type B Capsular Polysaccharide / by Fatme Mawas, Barbara Bolgiano, Danielle Belgrave, Dennis Crane, Peter Rigsby, and Michael J. Corbel
Mawas, Fatme; Bolgiano, Danielle; Crane, Dennis; Rigsby, Peter; Corbel, Michael J; World Health Organization. Biologicals Unit; WHO Expert Committee on Biological Standardization (2005 : Geneva, Switzerland) ( 2005 )
WHO_V-B_00.05_fre.pdf.jpg
Introduction du vaccin anti-Haemophilus influenzae type b dans les programmes de vaccination : principes directeurs pour la gestion et informations à l'intention des agents de santé et des parents
World Health Organization. Dept. of Vaccines and Biologicals ( 2000 )
WHO_V-B_00.05_eng.pdf.jpg
Introduction of Haemophilus Influenzae type b vaccine into immunization programmes : management guidelines, including information for health workers and parents
World Health Organization. Dept. of Vaccines and Biologicals ( 2000 )
WHO_IVB_12.08_eng.pdf.jpg
Measuring impact of streptococcus pneumoniae and haemophilus influenzae type b conjugate vaccination
World Health Organization ( 2012 )
WHO_IVB_12.08F_fre.pdf.jpg
Mesurer l'impact de la vaccination par les vaccins conjugués anti-streptococcus pneumoniae et anti-Haemophilus influenzae type b
Organisation mondiale de la Santé ( 2013 )
RA_2000_2_7-8_fre.pdf.jpg
Les pathologies à Haemophilus influenzae de type b en Asie : éditorial / Y.L. Lau
Lau, Y. L ( 2000 )
15_3_2009_0544_0548.pdf.jpg
Prevalence of oropharyngeal colonization by Haemophilus influenzae type b in Iranian children
Karimi, A.; Alborzi, A.; Fahimzad, A.; Gooya, M.; Esteghamati, A.; Armin, S.H.; Fallah, F. ( 2009 )
Abstract

Healthy carriers of Haemophilus influenzae type b [Hib] play an important role in the spread of invasive disease. The aim of this study was to assess the need for Hib vaccination in Iranian children by estimating the prevalence of Hib oropharyngeal colonization among children in Tehran. Cultures were prepared from oropharyngeal swabs of 1000 children in 25 day-care centres in Tehran from October 2005 to March 2006. The prevalence of Hib carriers was 7.6%, similar to other developing countries prior to inoculation with the conjugate Hib vaccine. We recommend Hib vaccination be included in the Iranian national programme of immunization

Showing results 1 to 20 of 36  next >